Congress Outlook: EMCC 2011 - Cancer Innovation Abounds
£500.00 + VAT (if applicable) Single User License
£1,500.00 + VAT (if applicable) Company License
Read all the buzz from this year’s European Multidisciplinary Cancer Congress (EMCC) in this comprehensive executive briefing, including:
- Expert commentary from Sally Church (renowned oncology analyst), Prof Richard Sullivan (leading medical oncologist) and Jan Geissler (vocal cancer epatient).
- Transcripts of interviews with the authors from critical trial results (including BOLERO-2) and panel group discussions on metastatic breast cancer and immunotherapy.
- A review of the digital and social media coverage of the Congress, including analysis of the circa 3,500 Tweets sent over the course of the meeting.
- Learn about key clinical updates from EMCC across various tumour types, including expert first-hand discussion from medical oncologists.
- Understand the changing stakeholder landscape in European oncology and how patient advocates and groups are becoming integral to decision making.
- Discover additional resources and media channels providing a wealth of information on EMCC critical to decision making in the oncology space